Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.7.0.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 1,333,114 $ 1,647,490
Accrued product development costs 1,246,527 713,426
Accrued compensation 122,175 778,250
Accrued other 172,302 117,289
Total $ 2,874,118 $ 3,256,455